Within-day and Between-day Repeatability of the Breath Pattern in Healthy Children and in Children With Asthma

NCT03025061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2018-09-05

No results posted yet for this study

Summary

"Within-day and Between-day Repeatability of the Breath Pattern in Healthy Children and in Children With Moderate Asthma" is an observational prospective study in outpatient clinic of Pediatric Allergology \& Pulmonology (PAP) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (IBIM CNR), Italy.

The electronic nose (E-nose) has been proposed as a novel, non-invasive tool to evaluate the level of airway inflammation for different respiratory diseases, especially in children. To date, there are no data on the within-day and the between-day repeatability of the breath pattern in healthy children and in children with moderate asthma.

The breath pattern will be analyzed by collecting, for each child, three samples of the breath through the E-nose. Within-day repeatability will be assessed using two consecutive measurements (the second one after 30 minutes). Between-day repeatability will be assessed using a third measurement repeated after 7 days.

The study is expected to provide information about the accuracy of E-nose measurements for a child population.

Conditions

Interventions

OTHER

Assessment of E-nose measurements

Breath sampling through E-nose pneumopipe

Sponsors & Collaborators

  • Campus Bio-Medico University

    collaborator OTHER
  • Istituto per la Ricerca e l'Innovazione Biomedica

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-24
Primary Completion
2018-08-03
Completion
2018-08-03

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025061 on ClinicalTrials.gov